NLRP3 and glomerular disorder: Specifically, NLRP3 activation drives glomerular disease through pyroptosis (Ke et al., 2020), leading to mesangial expansion (Tung et al., 2018) and glomerular thickening (Yanfei Liu et al., 2020).